PL3484907T3 - Nowe fosfotriazolowe analogi kapu końca 5’ mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu - Google Patents
Nowe fosfotriazolowe analogi kapu końca 5’ mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptyduInfo
- Publication number
- PL3484907T3 PL3484907T3 PL17754482T PL17754482T PL3484907T3 PL 3484907 T3 PL3484907 T3 PL 3484907T3 PL 17754482 T PL17754482 T PL 17754482T PL 17754482 T PL17754482 T PL 17754482T PL 3484907 T3 PL3484907 T3 PL 3484907T3
- Authority
- PL
- Poland
- Prior art keywords
- same
- rna molecule
- phosphotriazole
- mrna
- peptide
- Prior art date
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 title 2
- KKMDYQUDLZESGL-UHFFFAOYSA-N O=P(=O)C1=CNN=N1 Chemical compound O=P(=O)C1=CNN=N1 KKMDYQUDLZESGL-UHFFFAOYSA-N 0.000 title 1
- 108020004999 messenger RNA Proteins 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL417980A PL417980A1 (pl) | 2016-07-16 | 2016-07-16 | Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu |
| EP17754482.2A EP3484907B1 (en) | 2016-07-16 | 2017-07-12 | Novel phosphotriazole mrna 5'-end cap analogs, composition comprising the same, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule, protein or peptide |
| PCT/IB2017/054221 WO2018015845A1 (en) | 2016-07-16 | 2017-07-12 | Novel phosphotriazole mrna 5'-end cap analogs, composition comprising the same, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule, protein or peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3484907T3 true PL3484907T3 (pl) | 2021-02-08 |
Family
ID=59656110
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL417980A PL417980A1 (pl) | 2016-07-16 | 2016-07-16 | Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu |
| PL17754482T PL3484907T3 (pl) | 2016-07-16 | 2017-07-12 | Nowe fosfotriazolowe analogi kapu końca 5’ mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL417980A PL417980A1 (pl) | 2016-07-16 | 2016-07-16 | Nowe fosfotriazolowe analogi kapu końca 5' mRNA, kompozycja je zawierająca, cząsteczka RNA je zawierająca, ich zastosowania i sposób syntezy cząsteczki RNA, białka i peptydu |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10696709B2 (pl) |
| EP (1) | EP3484907B1 (pl) |
| CY (1) | CY1123516T1 (pl) |
| DK (1) | DK3484907T3 (pl) |
| ES (1) | ES2820242T3 (pl) |
| HR (1) | HRP20201274T1 (pl) |
| HU (1) | HUE051312T2 (pl) |
| LT (1) | LT3484907T (pl) |
| PL (2) | PL417980A1 (pl) |
| PT (1) | PT3484907T (pl) |
| RS (1) | RS60848B1 (pl) |
| SI (1) | SI3484907T1 (pl) |
| SM (1) | SMT202000583T1 (pl) |
| WO (1) | WO2018015845A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016146143A1 (en) | 2015-03-16 | 2016-09-22 | Amal Therapeutics Sa | Cell penetrating peptides and complexes comprising the same |
| EP3429618B1 (en) | 2016-03-16 | 2024-02-21 | Amal Therapeutics SA | Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicine |
| KR20190057345A (ko) | 2016-09-21 | 2019-05-28 | 아말 테라퓨틱스 에스에이 | 암 치료를 위한, 세포 투과 펩타이드, 멀티 에피토프 및 tlr 펩타이드 작용제를 포함하는 융합체 |
| WO2023250528A1 (en) | 2022-06-24 | 2023-12-28 | The Broad Institute, Inc. | Compositions and methods for preparing capped circular rna molecules |
| EP4464713A1 (en) | 2023-05-18 | 2024-11-20 | Siec Badawcza Lukasiewicz - PORT Polski Osrodek Rozwoju Technologii | Circular rna analogs, preparation and application thereof |
| AU2024328087A1 (en) | 2023-08-23 | 2026-04-02 | Massachusetts Institute Of Technology | Compositions and methods to improve rna properties using base, phosphodiester linkage, sugar backbone, and cap modifications |
| WO2025231018A2 (en) | 2024-04-30 | 2025-11-06 | The Broad Institute, Inc. | Therapeutic compositions and methods for producing and using the same |
| WO2025255113A1 (en) | 2024-06-04 | 2025-12-11 | The Broad Institute, Inc. | Compositions and methods for inducing rna translation |
| WO2026106497A2 (en) | 2024-11-18 | 2026-05-21 | Sieć Badawcza Łukasiewicz – Port Polski Osrodek Rozwoju Technologii | Functionalized circular rna and methods and intermediates for their production |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013059475A1 (en) * | 2011-10-18 | 2013-04-25 | Life Technologies Corporation | Alkynyl-derivatized cap analogs, preparation and uses thereof |
-
2016
- 2016-07-16 PL PL417980A patent/PL417980A1/pl unknown
-
2017
- 2017-07-12 PT PT177544822T patent/PT3484907T/pt unknown
- 2017-07-12 DK DK17754482.2T patent/DK3484907T3/da active
- 2017-07-12 ES ES17754482T patent/ES2820242T3/es active Active
- 2017-07-12 SM SM20200583T patent/SMT202000583T1/it unknown
- 2017-07-12 HU HUE17754482A patent/HUE051312T2/hu unknown
- 2017-07-12 HR HRP20201274TT patent/HRP20201274T1/hr unknown
- 2017-07-12 WO PCT/IB2017/054221 patent/WO2018015845A1/en not_active Ceased
- 2017-07-12 EP EP17754482.2A patent/EP3484907B1/en active Active
- 2017-07-12 LT LTEP17754482.2T patent/LT3484907T/lt unknown
- 2017-07-12 PL PL17754482T patent/PL3484907T3/pl unknown
- 2017-07-12 SI SI201730371T patent/SI3484907T1/sl unknown
- 2017-07-12 US US16/318,126 patent/US10696709B2/en active Active
- 2017-07-12 RS RS20200968A patent/RS60848B1/sr unknown
-
2020
- 2020-08-13 CY CY20201100762T patent/CY1123516T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE051312T2 (hu) | 2021-03-01 |
| WO2018015845A1 (en) | 2018-01-25 |
| ES2820242T3 (es) | 2021-04-20 |
| EP3484907A1 (en) | 2019-05-22 |
| SI3484907T1 (sl) | 2020-12-31 |
| HRP20201274T1 (hr) | 2020-12-11 |
| PT3484907T (pt) | 2020-09-17 |
| RS60848B1 (sr) | 2020-10-30 |
| CY1123516T1 (el) | 2022-03-24 |
| EP3484907B1 (en) | 2020-05-13 |
| SMT202000583T1 (it) | 2020-11-10 |
| PL417980A1 (pl) | 2018-01-29 |
| LT3484907T (lt) | 2020-09-10 |
| US10696709B2 (en) | 2020-06-30 |
| DK3484907T3 (da) | 2020-08-17 |
| US20200055891A1 (en) | 2020-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3484907T (pt) | Novos análogos de cobertura fosfotriazol da extremidade 5' de marn, composição compreendendo os mesmos, molécula de arn incorporando os mesmos, suas utilizações e método de síntese de molécula de arn, proteína ou péptido | |
| IL290633A (en) | 5'-cyclophosphonate modified nucleotides, preparations containing them and their uses | |
| ZA202501799B (en) | Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications | |
| IL256395B (en) | Stabilized antimicrobial peptides, preparations containing them and methods of producing them | |
| SG11202008225PA (en) | Novel rsv rna molecules and compositions for vaccination | |
| WO2015011694A3 (en) | Isotopologues of smad7 antisense oligonucleotides | |
| WO2016065349A8 (en) | Short non-coding protein regulatory rnas (sprrnas) and methods of use | |
| WO2016149455A3 (en) | The rna interactome of polycomb repressive complex 1 (prc1) | |
| PH12018501355A1 (en) | Rsv f protein mutants | |
| WO2015006747A3 (en) | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use | |
| WO2017191274A3 (en) | Rna encoding a therapeutic protein | |
| WO2016033315A3 (en) | Synthon formation | |
| EP4545544A3 (en) | Modified crispr rna and modified single crispr rna and uses thereof | |
| WO2016205531A3 (en) | Anti-her2 antibodies and methods of use | |
| WO2012017324A3 (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases | |
| PL3408276T3 (pl) | 5’-tiofosforanowe analogi końca 5’ mRNA (kapu), mRNA je zawierające, sposób ich otrzymywania i zastosowania | |
| EP3279207A4 (en) | Novel compound of 4'-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof | |
| WO2017025179A8 (en) | A transglutamine tag for efficient site-specific bioconjugation | |
| HK1252862A1 (zh) | 结合cd45的抗体分子 | |
| WO2012054907A3 (en) | Novel hemagglutinin 5 (h5) proteins for the treatment and prevention of influenza infections | |
| EP4218736A3 (en) | Compositions comprising 15-hepe | |
| WO2016020880A3 (en) | Angiopoietin-like 4 antibodies and methods of use | |
| WO2017007886A3 (en) | Compositions for inhibiting dux4 gene expression and uses thereof | |
| WO2016020882A3 (en) | Angiopoetin-like 4 (angptl4) antibodies and methods of use | |
| SG11202106327QA (en) | Oligomeric nucleic acid molecule and application thereof |